NCT05291858 is a clinical trial in Fallot Tetralogy, sponsored by Assiut University.

Who is sponsoring NCT05291858?

NCT05291858 is sponsored by Assiut University.

What condition does NCT05291858 study?

NCT05291858 studies Fallot Tetralogy.

Is NCT05291858 still recruiting?

NCT05291858 is currently status unknown. Last updated 23 March 2022.

Last reviewed 2022-03-23 · How we verify

NCT05291858

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computed Tomographic Assessment of Cardiac and Extra Cardiac Vascular Anomalies Associated With Tetralogy of Fallot

Status unknown Last updated 23 March 2022

What this trial tests

trial in Fallot Tetralogy in 25 participants. Status unknown.

Timeline

30 December 2023

Primary endpoint
30 December 2024

30 December 2025

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	25
Start date	30 December 2023
Primary completion	30 December 2024
Estimated completion	30 December 2025

Conditions studied

Fallot Tetralogy — all drugs for Fallot Tetralogy →

Sponsor

Assiut University

Who can join

Adults 1 Month to 18, any sex, with Fallot Tetralogy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of cardiac and extra cardiac vascular defects associated with Tetralogy of fallot in pediatric patients, regarding frequency and types of anomalies with assesment of multidetector computed tomography diagnostic value.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05291858 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 23 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05291858.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing